Condition: Meningeoma · Thrombembolism · Surgical Resection · Sponsor: University Hospital Tuebingen
Interested? Contact the study team ↓
Despite being generally benign tumors, meningiomas are associated with an increased risk for thrombembolic complications after surgical resection. The molecular mechanisms underlying this circumstance are still unknown. In this prospective observational trial, the investigators aim to evaluate the changes in coagulation and platelet function caused by tumor resection. Blood samples are obtained by patients undergoing meningioma resection before and immediately after resection to detect said changes. As a control cohort, blood samples are obtained from patients undergoing resection for glioma.
This description comes directly from the study's public registry record.
Michael Koeppen, MD · +4970712986935 · michael.koeppen@med.uni-tuebingen.de
Alice Bernard, MD · +4970712968028 · alice.bernard@med.uni-tuebingen.de
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Patients undergoing resection for meningioma or * Patients undergoing resection for glioma or * Healthy controls * written consent for study participation Exclusion Criteria: \-
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| University Hospital for Anaesthesiology and Intensive Care Medicine, Tuebingen | Tübingen, Baden-Wurttemberg, Germany | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.